Phase 2 Study of RSLV-132 in Subjects With Long COVID
Status:
Recruiting
Trial end date:
2022-03-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy (decrease in severe fatigue), safety and
pharmacokinetics of RSLV-132 in subjects with long Corona Virus (COVID) syndome